Advances in cancer diagnostic testing have revolutionized cancer treatment and care. At the Cancer Center at Illinois, scientists are using their multidisciplinary expertise to develop devices and techniques that address a number of limitations of current diagnostics. Currently, many ways to diagnose cancer can be invasive, expensive, limited (requiring additional testing), and require patients to wait days or weeks for a proper diagnosis. CCIL researchers are developing improved imaging techniques and molecular measurement devices – they can detect specific biologic molecules, or biomarkers, in a patient’s tissue and fluid samples – to tackle these issues.
Learn more about the CCIL’s research program themes dedicated to diagnostic technology.
